Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver.
MacKinnon AC, Humphries DC, Herman K, Roper JA, Holyer I, Mabbitt J, Mills R, Nilsson UJ, Leffler H, Pedersen A, Schambye H, Zetterberg F, Slack RJ.
MacKinnon AC, et al. Among authors: roper ja.
Eur J Pharmacol. 2024 Dec 15;985:177077. doi: 10.1016/j.ejphar.2024.177077. Epub 2024 Nov 9.
Eur J Pharmacol. 2024.
PMID: 39528104